CTRI/2020/06/026002
Not yet recruiting
Phase 2
Evaluation of Efficacy and Safety of Ayurveda Intervention (Ayush-64) add-on therapy for patients with COVID-19 infection (Stage I)-An Open labelled, Parallel Group, Randomized controlled clinical trial
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- ational Institute of Ayurveda
- Status
- Not yet recruiting
- Last Updated
- 4 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\.Patients of 18\-60 yrs of age, clinically diagnosed with corona virus disease 2019 by RTPCR test coming under stage I\- mild (Early infection)
- •2\.Participants who can take medicines orally.
- •3\.Patients willing to provide signed informed consent.
Exclusion Criteria
- •1\.Pregnant, Lactating women, patients with CKD (Chronic Kidney Disease).
- •2\.Not willing to participate in the study.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Not Applicable
Evaluation of Role of Ayurvedic Drug- Guduchi Ghan Vati in the treatment of COVID-19 related illnessCTRI/2020/05/025370Dr SR Rajasthan Ayurved University Jodhpur
Completed
Phase 3
Effect of Ayurveda intervention AYUSH-64 add-on therapy for patients with COVID-19 infection (Stage I)Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhereCTRI/2020/05/025156Central Council for Research in Ayurvedic Sciences60
Completed
Phase 2
Evaluation of Efficacy and Safety of Ayurveda Intervention (Ayush -64) in the management of COVID-19 infection (Asymptomatic &Mild to Moderate symptomsCTRI/2020/05/025338Central Council For Research in Ayurvedic Sciences40
Not yet recruiting
Not Applicable
Therapeutic role of Ayurvedic interventions in Amavata(Rheumatoid arthritis) with special reference to gut microbiotaCTRI/2020/10/028746AMRIT GODBOLE
Completed
Phase 2
Clinical trial of CIM-Meg19 in COVID-19 patientsCTRI/2021/05/033543Ms Meghdoot Gramodyog Sewa Sansthan80